Home › NDC Lookup › Ingredients › Enoxaparin Sodium › 25021-0410-71
💉image loading
(from DailyMed)

Enoxaparin Sodium 100 mg/mL Injection, 10 syringes — NDC 25021-410-71 (Billing 25021-0410-71)

by Sagent Pharmaceuticals · 10 SYRINGE in 1 CARTON / 1 mL in 1 SYRINGE

This is a package of 10 syringes of Enoxaparin Sodium 100 mg/mL Injection from Sagent Pharmaceuticals, marketed since Oct 2023 and currently FDA-listed; retail pharmacies pay about $6.45 per mL (NADAC).

NDC 25021-0410-71
🏷️ FDA NDC (as labeled) 25021-410-71 billing pads the product segment with a zero
This package
Contains10 syringes Cost per mL$6.45 NADAC Per package$64.52 / 10 ml Pack sizes5 compare ↓
Also priced by: Medicaid pays $8.03/unit · Part D plans $10.33/unit — full pricing hub ↓
Product page 25021-0410-76 Also comes in: 10 syringes 25021-410-70 10 syringes 25021-410-76 10 syringes 25021-410-77 10 syringes 25021-410-78
Rx only Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Oct 8, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 25021-410-71 alone.

Record
FDA NDC Directory package listing · Human prescription drug
Code segments
25021 labeler · 410 product · 71 package
Package marketed since
Oct 1, 2023
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Barcode (UPC-A, from the NDC)
3 2502141071 4
Medicaid fills, this package
40 prescriptions in the last four reported quarters
FDA record last changed
Oct 8, 2026
⚠️
Other active recalls for Enoxaparin Sodium (different manufacturers) — 1 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Aug 5, 2025 — Correct Labeled Product Mispack: Bags labeled for Enoxaparin Sodium Injection, 80 mg/0.8 mL, contained Enoxaparin Sodium Injection, 30 mg/0.3 mL (Cardinal Health Inc.) · FDA recall D-0597-2025
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 25021-410-71
Product NDC 25021-410
11-digit billing NDC 25021041071
NCPDP billing unit ML — per mL (volume)
Application # ANDA078990
SPL Set ID 89603c04-9b00-4528-8668-b8489308380f
Established class (EPC) Heparin; Low Molecular Weight Heparin
Chemical class Low-Molecular-Weight
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2023-10-01
Route SUBCUTANEOUS
Dosage form INJECTION
Substance ENOXAPARIN SODIUM
TE code (Orange Book) AP · RLD · RS

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GCN Seq No 027995
GCN 62773
HICL code 007878
Ingredient (HICL) Enoxaparin Sodium
HIC1 code M
Therapeutic class — broad (HIC1) Blood
HIC2 code M9
Therapeutic class — intermediate (HIC2) Drugs Given To Alter Blood Coagulation
HIC3 code M9K
Therapeutic class — specific (HIC3) Heparin And Related Preparations
AHFS code 20:12.04.16
AHFS class Heparins
FDB label name ENOXAPARIN 100 MG/ML SYRINGE
FDB brand name Enoxaparin Sodium
Legend status F — Federal legend — prescription drug or device
Quick answers
  • GSN (GCN sequence number): 027995
  • GCN: 62773
  • HICL (First Databank): 007878
  • AHFS class code: 20:12.04.16
Why two NDCs? The FDA registers this code as 25021-410-71 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 25021-0410-71. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name ENOXAPARIN 100 MG/ML SYRINGE Ingredient Enoxaparin Sodium
📗 Our plain-language guide HelloPharmacist
  • It is a blood thinner that helps prevent and treat deep vein thrombosis, a clot in a deep vein. It is also used in unstable angina and certain heart attacks. Your prescriber choose...
  • It is an injection, usually under the skin, and some uses involve an injection into a vein. How often depends on why you need it. Follow your prescriber’s directions and the produc...
  • Bruising, injection site pain, nausea and diarrhea are common. Some people have bleeding or a lower blood count. Call your doctor if bleeding seems unusual or won’t stop.
  • Yes. If you have an epidural or spinal procedure, bleeding near the spine can rarely cause permanent paralysis. Report new numbness, leg weakness or bladder or bowel changes right...
📖 Read our full Enoxaparin guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
1
Nutrient depletion considerations

Enoxaparin may be associated with lower levels of 1 nutrient — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Enoxaparin nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly $6.452 $64.52 / 10 ml
Medicaid paysCMS SDUD · 12 mo $8.03 $80.33 / 10 ml
Medicare drug plans payPart D · Q2 2026 $10.33 $103.33 / 10 ml
Medicare Part B allowsASP · J1650 $0.536 / J1650 unit —
NADAC price history (per mL) — tap or hover for the price & month
Dec 2025 Mar 2026 Jun 2026 Sep 2026 $8.605 $6.452
▼ Down 25% over the last 10 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Billing & reimbursement

FDA NDC (as labeled)25021-410-71
11-digit billing NDC25021-0410-71
Format5-3-2 as registered → padded to 5-4-2 for billing (zero added to the product segment)
HCPCS J-codeJ1650
DescriptorINJECTION, ENOXAPARIN SODIUM, 10 MG
Billing units / pkg10 units
How the units are derivedThis package is 1 ML; the HCPCS unit is 10 MG, so one package = 10 billing units.
Medicare Part B spend (2026 (Q1))$24,269 · 288 claims · $84.27 per claim (all NDCs under J1650)
Crosswalk sourcePDAC NDC-HCPCS crosswalk (DME MAC / DMEPOS)
Where does this data come from?
The HCPCS J-code crosswalk comes from the CMS ASP NDC-HCPCS crosswalk and the DMEPDAC (DME MAC) NDC-HCPCS crosswalk — free public CMS data. Billing units are derived from the code’s descriptor and the package amount.

Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startMarketing endStatus
25021-0410-70 25021-410-70 10 SYRINGE in 1 CARTON / .3 mL in 1 SYRINGE $9.13 / mL $27.38 2023-10-01 — Active
25021-0410-71 You're viewing this 10 SYRINGE in 1 CARTON / 1 mL in 1 SYRINGE $6.45 / mL $64.52 2023-10-01 — Active
25021-0410-76 25021-410-76 Main listing 10 SYRINGE in 1 CARTON / .4 mL in 1 SYRINGE $7.78 / mL $31.12 2023-10-01 — Active
25021-0410-77 25021-410-77 10 SYRINGE in 1 CARTON / .6 mL in 1 SYRINGE $7.45 / mL $44.71 2023-10-01 — Active
25021-0410-78 25021-410-78 10 SYRINGE in 1 CARTON / .8 mL in 1 SYRINGE $6.69 / mL $53.49 2023-10-01 — Active

This pack has the lowest per-mL cost of the 5 priced pack sizes ($6.45 NADAC).

This pack accounts for about 0.8% of this product's recent Medicaid fills; most go to a different pack size. See all packs ↓

Pack size FAQ

What quantity is in this package?
This package contains 10 syringes — 10 syringe in 1 carton / 1 ml in 1 syringe.
How does this package differ from NDC 25021-0410-70?
Both are Enoxaparin Sodium 100 mg/mL Injection — the drug itself is identical. This page's package is the 10 syringes one, while NDC 25021-0410-70 is the 10 syringes package. Per-mL NADAC also differs: $6.45 here vs $9.13 for the 10 syringes pack.
What NDC number is used to bill for this package of Enoxaparin Sodium 100 mg/mL Injection?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Enoxaparin Sodium 100 mg/mLthis 25021-0410-71 Sagent 10 syringes $6.452 AP Availability likely —
enoxaparin sodium 100 mg/mL 71839-0113-10 BE 10 syringes $6.452 AP Availability likely —
Enoxaparin Sodium 100 mg/mL 16714-0046-10 NorthStar 10 syringes $6.452 AP Availability likely —
Enoxaparin Sodium 100 mg/mL 63323-0586-65 Fresenius 1 syringe $6.452 AP Availability likely —
Enoxaparin Sodium 100 mg/mL 81952-0130-06 Hepalink 10 syringes $6.452 AP Availability likely —
Enoxaparin Sodium 100 mg/mL 00781-3268-69 Sandoz 10 syringes $6.452 AP Availability likely —
Enoxaparin Sodium 100 mg/mL 71288-0436-92 Meitheal 10 syringes $6.452 AP Availability likely —
Enoxaparin sodium 100 mg/mL 00955-1010-10 Sanofi-Aventis 10 cellos $6.452 AP Availability likely —
Enoxaparin Sodium 100 mg/mL 00548-5605-00 Amphastar 10 syringes $6.452 AP Availability likely —
Enoxaparin Sodium 100 mg/mL 68001-0637-42 BluePoint 10 syringes $6.452 AP Availability likely —
Enoxaparin Sodium 100 mg/mL 63323-0605-94 Fresenius 10 cellos $6.593 AP Availability likely +2%
Enoxaparin Sodium 100 mg/mL 00781-3262-68 Sandoz 10 syringes $6.687 AP Availability likely +4%
Enoxaparin Sodium 100 mg/mL 68001-0636-42 BluePoint 10 syringes $6.687 AP Availability likely +4%
Enoxaparin Sodium 100 mg/mL 71288-0435-92 Meitheal 10 syringes $6.687 AP Availability likely +4%
Enoxaparin Sodium 100 mg/mL 00548-5604-00 Amphastar 10 syringes $6.687 AP Availability likely +4%
Enoxaparin Sodium 100 mg/mL 16714-0036-10 NorthStar 10 syringes $6.687 AP Availability likely +4%
Enoxaparin Sodium 100 mg/mL 68001-0460-42 BluePoint 10 syringes $7.127 AP Availability likely +10%
Enoxaparin Sodium 100 mg/mL 68001-0461-42 BluePoint 10 syringes $7.370 AP Availability likely +14%
Enoxaparin Sodium 100 mg/mL 68001-0459-42 BluePoint 10 syringes $7.452 AP Availability likely +16%
Enoxaparin Sodium 100 mg/mL 00548-5603-00 Amphastar 10 syringes $7.452 AP Availability likely +16%
Enoxaparin Sodium 100 mg/mL 16714-0026-10 NorthStar 10 syringes $7.452 AP Availability likely +16%
Enoxaparin Sodium 100 mg/mL 00781-3256-66 Sandoz 10 syringes $7.452 AP Availability likely +16%
Enoxaparin Sodium 100 mg/mL 68001-0635-42 BluePoint 10 syringes $7.452 AP Availability likely +16%
Enoxaparin Sodium 100 mg/mL 71288-0434-92 Meitheal 10 syringes $7.452 AP Availability likely +16%
Enoxaparin Sodium 100 mg/mL 68001-0458-42 BluePoint 10 syringes $7.779 AP Availability likely +21%
Enoxaparin Sodium 100 mg/mL 71288-0433-92 Meitheal 10 syringes $7.779 AP Availability likely +21%
Enoxaparin Sodium 100 mg/mL 00781-3246-64 Sandoz 10 syringes $7.779 AP Availability likely +21%
Enoxaparin Sodium 100 mg/mL 68001-0634-42 BluePoint 10 syringes $7.779 AP Availability likely +21%
Enoxaparin Sodium 100 mg/mL 00548-5602-00 Amphastar 10 syringes $7.779 AP Availability likely +21%
Enoxaparin Sodium 100 mg/mL 16714-0016-10 NorthStar 10 syringes $7.779 AP Availability likely +21%
Enoxaparin Sodium 100 mg/mL 68001-0457-42 BluePoint 10 syringes $9.127 AP Availability likely +41%
Enoxaparin Sodium 100 mg/mL 71288-0432-92 Meitheal 10 syringes $9.127 AP Availability likely +41%
Enoxaparin Sodium 100 mg/mL 00548-5601-00 Amphastar 10 syringes $9.127 AP Availability likely +41%
Enoxaparin Sodium 100 mg/mL 16714-0006-10 NorthStar 10 syringes $9.127 AP Availability likely +41%
Enoxaparin Sodium 100 mg/mL 68001-0633-42 BluePoint 10 syringes $9.127 AP Availability likely +41%
Enoxaparin Sodium 100 mg/mL 00781-3238-63 Sandoz 10 syringes $9.127 AP Availability likely +41%
Enoxaparin Sodium 100 mg/mL 72603-0205-10 NorthStar 10 syringes $9.666 AP FDA listed +50%
Enoxaparin Sodium 100 mg/mL 72572-0280-10 Civica, 10 syringes — AP FDA listed —
Enoxaparin Sodium 100 mg/mL 55154-3540-05 Cardinal 5 syringes — AP FDA listed —
Enoxaparin Sodium 100 mg/mL 55154-3542-05 Cardinal 5 syringes — AP FDA listed —
Enoxaparin Sodium 100 mg/mL 55154-3543-05 Cardinal 5 syringes — AP FDA listed —
Enoxaparin Sodium 100 mg/mL 55154-3544-05 Cardinal 5 syringes — AP FDA listed —
Enoxaparin Sodium 100 mg/mL 68083-0638-10 Gland 10 syringes — AP FDA listed —
enoxaparin sodium 100 mg/mL 28955-0105-10 Hebei 10 syringes — AP FDA listed —
Lovenox 100 mg/mL 00075-0623-00 Sanofi-Aventis 10 cellos — AP FDA listed —
Lovenox 100 mg/mL 00075-8020-10 Sanofi-Aventis 10 cellos — AP FDA listed —
Enoxaparin Sodium 100 mg/mL 55154-3541-05 Cardinal 5 syringes — AP FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2023
On the market since
Oct 2023
📍
2026
Currently FDA-listed
3 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Enoxaparin inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerSagent Pharmaceuticals
Application holderGLAND PHARMA LTD
FDA applicationANDA078990 (ANDA)
Labeler code25021
First marketedOct 2023
Product typeHuman Prescription Drug
Portfolio209 products on file

More NDCs from Sagent Pharmaceuticals labeler code 25021

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 FDA label
📄 FDA label 19 words ▾

No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
40
Units reimbursed last 4 qtrs
826
Gross reimbursed last 4 qtrs
$6.6K
Avg / prescription
$165.87
Avg / unit
$8.0327
Latest quarter Q1 2026
0Rx
Medicaid pays / mL
$8.0327
gross reimbursed
vs
NADAC / mL
$6.4517
acquisition cost
=
Spread
+$1.5810
+25% vs cost
What Medicaid paid per mL (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
100% MCO
Fee-for-service · 0 Rx Managed care · 40 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: no data reported MN Wisconsin: no data reported WI Michigan: no data reported MI New York: no data reported NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: no data reported OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: no data reported IN Ohio: 297 units · 2.5 per 100k residents OH Pennsylvania: no data reported PA New Jersey: no data reported NJ Massachusetts: no data reported MA California: no data reported CA Utah: no data reported UT Colorado: no data reported CO Nebraska: no data reported NE Missouri: no data reported MO Kentucky: 358 units · 7.9 per 100k residents KY West Virginia: no data reported WV Virginia: 171 units · 2.0 per 100k residents VA Maryland: no data reported MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: no data reported AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
2.07.9
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Kentucky 7.9 /100k
2 Ohio 2.5 /100k
3 Virginia 2.0 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
10 syringes25021-0410-76 5,001 Rx · $462,301
10 syringes25021-0410-70 167 Rx · $12,193
10 syringes25021-0410-77 52 Rx · $10,151
10 syringes this page25021-0410-71 40 Rx · $6,635
10 syringes25021-0410-78 No Medicaid data
Drug total (last 4 qtrs): 5,260 Rx · 11,302 units · $491,280 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Enoxaparin Sodium — the program that covers self-administered drugs. 13 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Enoxaparin Sodium. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$20.1M
Claims incl. refills
131.2K
Beneficiaries
84K
Spend / beneficiary
$239.28
Spend / claim
$153.24
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.
← 25021-0408-51 · Sagent 25021-0411-70 · Sagent →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.